A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity
Diefenbach A, Hsia JK, Hsiung MY, Raulet DH. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur J Immunol 2003; 33: 381-391
Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF
Robertson MJ, Soiffer RJ, Wolf SF, Manley TJ, Donahue C, Young D et al. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med 1992; 175: 779-788
Antitumor and antimetastatic activity of interleukin 12 against murine tumors
Brunda MJ, Luistro L, Warrier RB, Hubbard BR, Murphy M, Wolf SF et al. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 1993; 178: 1223-1230
Inhibition of angiogenesis in vivo by interleukin 12
OReilly
Voest EE, Kenyon BM, OReilly MS, Truitt G, DAmato RJ, Folkman J. Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 1995; 87: 581-586
Identification of the murine beige gene by YAC complementation and positional cloning
Perou CM, Moore KJ, Nagle DL, Misumi DJ, Woolf EA, McGrail SH et al. Identification of the murine beige gene by YAC complementation and positional cloning. Nat Genet 1996; 13: 303-308
Vitro and in vivo delivery of novel anticancer fusion protein MULT1E/FasTI via adenoviral vectors
Kotturi HS, Li J, Branham-OConnor M, Yu X, Wagner TE, Wei Y. In vitro and in vivo delivery of novel anticancer fusion protein MULT1E/FasTI via adenoviral vectors. Cancer Gene Therapy 2010; 17: 164-170